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MK (midkine) and HB-GAM (heparin-binding growth-associated molecule) constitute a
new family of heparin-binding growth differentiation factors. The modes of expression of
MK and HB-GAM during mouse development were quantitatively examined by mRNA
hybridization. The following three distinct patterns of expression were observed in the
brain/head region. On the llth-13th days of gestation, MK was intensely, but HB-GAM
relatively weakly expressed; on the 15th-19th days, both MK and HB-GAM expression
became weaker; and in the neonatal period, HB-GAM was intensely expressed and MK
expression increased slightly. The level of HB-GAM expression was lower than that of MK
in the whole embryo on the 11th to 13th days of gestation. HB-GAM mRNA was detected in
the kidney of newborn and young mice, where MK was more highly expressed. The identity
of the weakly expressed MK and HB-GAM signals was confirmed by means of the
polymerase chain reaction in the neonatal brain (MK), the head of 13-day embryos
(HB-GAM), and the kidney of 7-day-old mice (HB-GAM). In conclusion, MK and HB-GAM
are frequently co-expressed in the same cells and anatomic regions of the fetus or new born
mouse, while their modes of expression differ.

Cytokines or growth factors are important in the regulation
of proliferation, differentiation and other cellular activities
(1-4). Pleiotropy and redundancy are characteristic features of most cytokines. For example, each interleukin has
multiple functions, whereas some of them induce the same
cell response (5). Furthermore, members of the FGF
family promote the growth of various cells, as well as
angiogenesis and mesoderm induction. Acidic FGF and
basic FGF display similar functions by binding to their
receptors (6, 7).
Among the heparin-binding growth factors, fibroblast
growth factors (FGFs) are the best characterized (6).
Recently, a new family of heparin-binding growth differentiation factors was identified, which are structurally
unrelated to FGF. The initial member of the new family is
midkine (MK), which is the product of a retinoic acid
responsive gene (8, 9). MK is a secreted protein rich in
cysteine and basic amino acids with a molecular mass of
around 13,000 (20). The heparin-binding growth-associated molecule (HB-GAM) exhibits about 50% homology with
MK at the amino acid level, and all cysteine residues are
conserved in MK and HB-GAM (22). HB-GAM has been
identified in 4 different laboratories, and has also been
called pleiotrophin (12), OSF-1 (13), and HBNF (14).
RI-HB, recently identified in chick embryos, which exhibits
1
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65% homology with MK, is probably the chick counterpart
of MK (15).
The genomic structures of human and mouse MK are
highly conserved in their exons and their exon-intron
boundaries and in discrete segments in the 5' upstream
regions (16, 17). Moreover, comparison of the murine
genomic structures of MK (26) and HB-GAM (18) revealed
that these genes have the same exon-intron arrangement,
similarly or identically sized exons and highly homologous
sequences in exons. These findings strongly suggest that the
MK and HB-GAM genes are derived from a common
ancestral gene (18).
MK, HB-GAM and RI-HB exhibit neurite extension
activity, and some of them also exhibit weak mitogenic
activity toward fibroblasts and PC12 pheochromocytoma
cells (10-12, 15, 19). In addition, HB-GAM exhibits
mitogenic activity toward capillary endothelial cells (20),
and is secreted from breast cancer cells and functions as a
tumor growth factor (21).
MK is predominantly expressed in the mid-gestation
embryo in the mouse (22). In situ hybridization revealed
that the principal sites of MK expression in mid-gestation
mouse embryos were epithelial cells, the brain, mesoderm
cells, and the kidney (22). However, in situ hybridization
experiments lack quantitative information. Furthermore,
because of the 52% homology between MK and HB-GAM
cDNAs, cross reaction should be rigorously excluded.
HB-GAM is principally expressed in neonatal and perinatal
brain of the rat (11, 12).
In order to understand the functions of these proteins in
mouse embryogenesis, we need precise knowledge on the
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modes of expression of these proteins. Here, we used
probes specific for MK and HB-GAM, and quantitatively
analyzed the expression of each heparin-binding protein
during mouse development. Because of the neurite extension activity of MK and HB-GAM, we focussed upon the
expression of these proteins in the brain. Furthermore, the
identity of weak signals was confirmed by means of the
polymerase chain reaction.
MATERIALS AND METHODS
Embryos and Organs—Embryos were obtained from
ICR mice after natural mating. The day when a vaginal plug
was detected was taken as day 0 of pregnancy.
Organs were obtained from day 11-19 embryos and from
mice at later stages. The excised organs were immediately
frozen in dry ice-ethanol and then stored at — 80'C until
RNA extraction.
Polymerase Chain Reaction, DNA Sequence Analysis,
and Southern Blotting—The polymerase chain reaction
(PCR) was performed as described (23) using primers
synthesized with a DNA synthesizer (Pharmacia LKB
Biotechnology) and templates synthesized from appropriate mRNA with reverse transcriptase. Denaturation was
performed at 93°C for 1 min, annealing at 50"C for 2 min,
and extension at 72*C for 3 min. Twenty-five cycles were
performed. The PCR products were separated by 1%
agarose gel electrophoresis, transferred to nitrocellulose
filters, and then hybridized with specific probes (24). In one
case, the synthesized DNA recovered from agarose gel
electrophoresis was cloned into PUC18 and sequenced by
the dideoxy chain termination method (25, 26).
Probes—The MK probe was derived from the 3' untranslated region of mouse MK cDNA [nucleotide numbers 421674(9)].
We synthesized a 411 bp fragment by PCR, which
corresponds to the 3' untranslated region of the mouse
HB-GAM cDNA [nucleotide numbers 722-1132 (23)],
using two nucleotide fragments (sense and antisense
strands comprising nucleotide numbers 722-731 and 11231132, respectively) as primers and cDNA from the brain of
14-day-old mice as a template. The sequence of the PCR
product differed by one nucleotide from that published
(13), possibly because of a mutation during PCR (nucleotide number 722, A-»G). There is no significant
sequence homology between these two probes, according to
the results of computer analysis. That these MK and
HB-GAM probes specifically detect MK and HB-GAM
mRNA was confirmed by Northern blotting using mRNA
from the head of a 13 day embryo and the brain of a
1-day-old mouse.
Mouse /?-actin cDNA used as a reference probe was a gift
from Prof. K. Shimada, Osaka University.
RNA Extraction—Total RNA was prepared by acid
guanidinium thiocyanate-phenol-chloroform extraction
(27). Briefly, organs or cells were homogenized with a
Polytron in solution D (4 M guanidinium thiocyanate, 25
mM sodium citrate, pH7.0, 0.5% sarcosyl, 0.1 M 2mercaptoethanol), and then debris was removed by centrifugation at 10,000Xg for 15 min. To the supernatant, 0.1
volume of 2 M sodium acetate (pH 4.0), 1 volume of phenol,
and 0.2 volume of chloroform were added sequentially.
After centrifugation, the aqueous phase was mixed with 1
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volume of isopropanol, followed by standing at — 20*C for 1
h to precipitate RNA. RNA was pelleted by centrifugation,
dissolved in solution D, and then precipitated with isopropanol. After washing with 70% ethanol, the RNA was
stored in ethanol at — 80"C until RNA analysis.
Poly A+ RNA was purified by oligo(dT)-cellulose chromatography from total RNA prepared by the guanidinium,
cesium chloride method (24).
RNA Analysis—For slot blot hybridization, 20 //g of
total RNA was applied to nitrocellulose filters using an
apparatus from Schleicher and Schuell. The filters were
hybridized with [32P]dCTP (Du Pont/NEN, 111 TBq/
mmol)-labeled cDNA generated by the random oligonucleotide primer method (28) at 42°C overnight, and then
washed twice for 10 min with 2 X SSC/0.1% SDS at room
temperature and twice for 30 min with 0.1 x SSC/0.1%
SDS at 55'C.
For Northern blotting, 10 peg of poly A+ RNA was
denatured with glyoxal, electrophoresed on a 1.0% agarose
gel (24), and then blotted onto nitrocellulose filters. The
conditions for hybridization and washing of the filters were
identical to those used for slot blot analysis.
RESULTS
MK and HB-GAM Expression during Embryogenesis—
The expression of MK and HB-GAM messages was examined using RNAs extracted from the brain or head by
slot blot analysis (Figs. 1 and 2).
As expected from the previous work (22), MK RNA was
highly expressed in the head of day 11 and day 13 embryos.
In situ hybridization revealed that the sites of the message
were the neuroectoderm around the lens and the brain
ventricle, etc. {22). MK expression decreased during
embryogenesis, but MK RNA was detectable at some level
in the head of late embryos and the brain of post-natal mice
(Figs. 1 and 2). The slight increase in MK mRNA in the
neonatal period is interesting. Previous studies involving in
situ hybridization showed that MK RNA was not significantly detectable in these regions after day 15 (22). Thus,
a more sensitive method allowed the detection of weak MK
signals. In this context we also noticed that slot blot
analysis showed a very faint signal of MK in the brains of
adult mice as well (8).
Since the MK message was weak in later embryos, and in
the neonatal and adult brain, it was necessary to confirm its
identity in representative cases. We therefore amplified
putative MK cDNA from the brain of 1-day-old and adult
mice by PCR using specific MK primers. In the neonatal
brain, the expected PCR product was present and it
hybridized with a specific MK probe (Fig. 3, lane 3). In the
adult brain, PCR yielded the product of expected size (data
not shown) and the identity of the MK signal was further
confirmed by sequence analysis: in nucleotide numbers
195-238, there was no sequence difference from the
published one (9). In this particular experiment different
primers (a sense strand comprising nucleotide numbers
175-194, and an antisense strand comprising nucleotide
numbers 239-258) were used.
HB-GAM was expressed in the head of 11-13 day
embryos relatively weakly (Fig. 1). HB-GAM expression
decreased as embryogenesis proceeded. In the neonatal
brain, HB-GAM expression became intense and the high
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Fig. 1. The expression of the
MK and HB-GAM genes during
mouse development. Total
RNAs (20 /ig) from whole embryo
(W), head (H), brain (B), liver
(L), and kidney (K) were blotted
onto nitrocellulose membranes
and then hybridized with ["P]dCTP-labeled MK, HB-GAM, or
/S-actin probe. E denotes days of
gestation, while P denotes days
after birth.

2

3

Fig. 3. PCR detection of MK and
HB-GAM cDNAs. Poly A+ RNAs were
i ..
prepared from 13 day embryo head
: ^r"1"
(lane 1), neonatal kidney (lane 2), and
neonatal brain (lane 3). cDNAs synthesized from 1 n% of poly A+ RNAs were
used as templates for PCR. Two syn1419 4P
thetic oligonucleotides were used as
primers; for MK, a sense strand com^_
prising nucleotide numbers 12-31 and
517 396^B
an antisense strand comprising nucleo214tide numbers 464-483 (9); for HBGAM, a sense strand comprising nucleotide numbers 1-20 and an antisense
strand comprising nucleotide numbers
1123-1132 (23). The PCR product was electrophoresed on a 1%
agarose gel, transferred to a nitrocellulose filter, and then hybridized
with either the [3IP]dCTP-labeled HB-GAM (lanes 1 and 2) or MK
(lane 3) probe.
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Fig. 4. Comparison of MK and HB-GAM expression between
the embryonic brain and the embryonic head region. Total RNAs
(20 n g) from the brain (B) and the head (H) of a day 17 embryo were
used for slot blot analysis, as in Fig. 1.
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Fig. 2. Quantitative changes in MK (O, • ) and HB-GAM (•, • )
expression during head (O, • ) and brain (a, • ) development
The hybridization signals in Fig. 1, quantitated with a LKB UltroScan
XL laser densitometer, were normalized as to the signals of /J-actin
mRNA and then plotted.

level continued until the 21st day after birth (Figs. 1 and 2).
The expression pattern in the neonatal brain is consistent
with that in the rat brain (11). The identity of the HB - GAM
message in the head of 13 day embryos was also confirmed
by PCR (Fig. 3, lane 1). Thus, the postnatal period is the
stage when HB-GAM is intensely expressed, whereas the
significant level of HB-GAM expression in the midgestation period should be kept in mind.
In the present study, we analyzed the head region instead
of the brain during embryonic periods, since rapid processing is essential to comparatively measure the mRNA
content accurately. However, in the 17 day embryo, we also
prepared mRNA from the brain, and measured MK and

HB-GAM mRNA, and confirmed that they were also low in
the brain in that period, although the HB-GAM mRNA
level was slightly higher in the brain than in the head (Fig.
4). The strong expression of MK in the head of 11-13 day
embryos is principally due to the brain, as shown by in situ
hybridization (22).
The modes of MK and HB-GAM expression in whole
embryos paralleled those in the head. However, the expression in the liver was weak or barely detectable (Fig. 1).
MK and HB-GAM Expression in Neonatal and Perinatal Kidney—MK RNA was detected by in situ hybridization at the onset of kidney formation, and was expressed
throughout development (22). In adult mice, only the
kidney (8) and, to a lesser degree, the uterus expressed MK
RNA at significant levels (29). However, no data are
available regarding quantitative changes in MK expression
during kidney development. We therefore examined this
by slot blot analysis. MK RNA was expressed in the
kidneys of day 15 embryos, and the expression level
remained constant during embryogenesis (data not shown).
After birth, MK was expressed most intensely in the
neonatal kidney (Fig. 1). In postnatal mice, MK expression
in the kidney was distinctly greater than that in other
organs. HB-GAM was also expressed in the kidney during
development, although at lower levels than that in the
brain. That the low level of the HB-GAM mRNA indeed
specifies for HB-GAM sequence was confirmed by PCR
(Fig. 3, lane 2).
DISCUSSION
The expression patterns of the two members of a newJ. Biochem.
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heparin binding growth/differentiation factor family, MK
and HB-GAM, were compared during mouse development.
In the brain/head region, MK was intensely expressed
during midgestation (days 11-13 of embryogenesis). Low
but significant HB-GAM expression accompanied MK
expression in that period. Then, expression of both MK and
HB-GAM decreased. HB-GAM expression strongly increased after birth and remained at a high level until 21
days after birth. A slight but significant increase was noted
in MK expression during the postnatal period. This period
correlates with the rapid growth of the brain, when axons
and dendrites grow out, and glial growth starts (30). It
should be borne in mind that both MK and HB-GAM
enhance neurite outgrowth (11, 12, 19), and it is likely that
HB-GAM and, to a lesser extent, MK promote neurite
outgrowth in vivo at this stage.
MK was intensely and continuously expressed in the
developing kidney after birth. HB-GAM was expressed in
the kidney at a much lower level. The functions of both
factors in nephrogenesis or in the adult kidney remain to be
elucidated.
Retinoic acid, which is a derivative of vitamin A, is
involved in diverse processes of development, and controls
cell differentiation and morphogenesis (31, 32). The expression of MK is induced by retinoic acid, yet there have
been no reports indicating the effect of retinoic acid on the
expression of HB-GAM. It is possible that HB-GAM
expression is controlled by a substance other than retinoic
acid, and that such a difference contributes to the different
modes of expression of the two heparin-binding growth
differentiation factors. Alternatively, HB-GAM expression
might also be controlled by retinoic acid, while other
requirements necessary for the induction of expression
differ between MK and HB-GAM.
The expression of MK and that of HB-GAM in the head
of the mid-gestation embryo, the postnatal brain, and the
postnatal kidney exhibit a reciprocal relationship. It is
important to note that in these regions both MK and
HB-GAM messages were detected even though one was
weak, and that the identity of the weak message was
confirmed by PCR. The biological meaning of the redundant
messages and their reciprocal modes of expression are
challenging problems to be solved.
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